Cost-Effectiveness Analysis in Public Health Genomics and Precision Health: Recent Findings, Methodologic Issues, and the Path Forward

 October 26, 2023, 11:00 am – 12:00 pm ET

David Veenstra

David Veenstra, PhD

CHOICE FacultyDepartment of PharmacyPharmacogenomics Research NetworkPharmacy FacultySchool Faculty, University of Washington, Seattle


Dr. Veenstra is a professor in the Department of Pharmacy and the Comparative Health Outcomes, Policy & Economics (CHOICE) Institute at the University of Washington. He graduated from the University of California, San Francisco with doctoral degrees in clinical pharmacy and computational chemistry. He conducted his postdoctoral training in health economics and outcomes research with the University of Washington, including a 1-year externship with Roche Global Pharmacoeconomics. Dr. Veenstra’s primary research interests are the clinical, economic, and policy implications of using genomic information in health care. His major research projects include evaluation of the cost-effectiveness of population-level genomic screening, pharmacogenomics in diverse populations, decision modeling techniques to assess evidence thresholds, and stakeholder preferences for precision medicine. Dr. Veenstra’s research has been funded through grants from the National Human Genome Research Institute, Centers for Disease Control and Prevention, National Cancer Institute, and the National Institute for General Medical Sciences. Dr. Veenstra has worked extensively with organizations such as the Academy of Managed Care Pharmacy (AMCP) and the Institute for Clinical and Economic Review (ICER) to further the practical application of cost-effectiveness analysis in managed care decision-making. Dr. Veenstra teaches courses in pharmacoeconomics and managed care and is an author or co-author of five book chapters and more than 200 peer-reviewed publications.

Selected References

Population Screening

Diagnosis of Genetic Diseases

Non-Genomic Precision Health



Hosted by

  • Public Health Genomics Branch in the Division of Blood Disorders and Public Health Genomics, Centers for Disease Control and Prevention
  • Precision Public Health Network